Hypertensive Disorders of Pregnancy - the Neonatal Burden of Disease
An Investigation of the Neonatal Burden of Disease of Hypertensive Disorders of Pregnancy: a Population-based Study Using the National Neonatal Research Database
1 other identifier
observational
823,957
1 country
1
Brief Summary
Around one in ten women have high blood pressure in pregnancy. This is potentially serious, with risks to the woman and her baby. Whilst maternal deaths from high blood pressure in pregnancy are now rare in the UK, blood pressure problems in pregnancy still cause many stillbirths and early births. Studies have shown that women of Black and Asian backgrounds are more likely to have worse pregnancy outcomes when blood pressure problems in pregnancy develop. This study aims to: i) describe the burden of disease of high blood pressure in pregnancy amongst babies admitted to neonatal units on a national scale. ii) investigate outcomes for babies born to women with high blood pressure in pregnancy admitted to UK neonatal units across maternal ethnic groups. To complete this study, we will use the National Neonatal Research Database, which holds population-level data for all babies admitted to neonatal units (where unwell babies receive care) in the UK. We will look at records of babies admitted to neonatal units in England and Wales between 2012 and 2020. The records will include information on over half a million babies and their mothers. We will assess how many babies admitted to neonatal units were born to women who had high blood pressure in pregnancy. We will report the outcomes of these babies, and how they compare to babies born to women without high blood pressure in pregnancy. We will analyse whether outcomes for babies born to women with high blood pressure in pregnancy varies according to maternal ethnicity, and investigate what may be driving differences we find.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2021
CompletedFirst Submitted
Initial submission to the registry
August 10, 2021
CompletedFirst Posted
Study publicly available on registry
August 20, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2025
CompletedOctober 15, 2024
October 1, 2024
4.3 years
August 10, 2021
October 11, 2024
Conditions
Outcome Measures
Primary Outcomes (4)
Survival to discharge from neonatal care
Survival to discharge from neonatal care
From birth to discharge or death, assessed up to 1 year
Primary recorded reason for neonatal unit admission
Primary recorded reason for neonatal unit admission
From birth to discharge or death, assessed up to 1 year
Length of stay in neonatal unit
Length of stay in neonatal unit
From birth to discharge or death, assessed up to 1 year
Number of days of intensive care
Number of days of intensive care
From birth to discharge or death, assessed up to 1 year
Secondary Outcomes (20)
Survival to discharge from neonatal care without comorbidity
From birth to discharge or death, assessed up to 1 year
Cause of death
From birth to discharge or death, assessed up to 1 year
Age at death
From birth to discharge or death, assessed up to 1 year
Discharge weight SDS (standard deviation score)
From birth to discharge or death, assessed up to 1 year
Birthweight centile (z-score)
From birth to discharge or death, assessed up to 1 year
- +15 more secondary outcomes
Study Arms (2)
Neonatal population - hypertensive disorder of pregnancy
All babies born to a woman with a hypertensive disorder of pregnancy (HDP) and admitted to a neonatal unit in England and Wales between 1st January 2012 and 31st December 2020
Neonatal population - no hypertensive disorder of pregnancy
All babies born to a woman without a hypertensive disorder of pregnancy (HDP) and admitted to a neonatal unit in England and Wales between 1st January 2012 and 31st December 2020
Eligibility Criteria
Babies born between 1st January 2012 and 31st December 2020 and admitted to a neonatal unit in England or Wales
You may qualify if:
- Must be born between 1st January 2012 and 31st December 2020
- Must be admitted to and received all care in a National Health Service (NHS) neonatal unit in England or Wales
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Imperial College London
London, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cheryl Battersby
Imperial College London
- PRINCIPAL INVESTIGATOR
Lucy Chappell
King's College London
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 10, 2021
First Posted
August 20, 2021
Study Start
July 1, 2021
Primary Completion
September 30, 2025
Study Completion
September 30, 2025
Last Updated
October 15, 2024
Record last verified: 2024-10